Banking, Finance & Insurance Global On demand · 24-48h

Global Blood Bank Information System Market Strategic Research Report

Global Blood Bank Information System Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Bank Information System Market
$5102025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Blood Donor Management Module, Blood Bank Transfusion Service Module, Other

By Application: Hospital, Blood Station

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Roper Industries, Haemonetics, Cerner Corporation, McKesson, Mak-System, Integrated Medical Systems, Mediware, Compugroup, SCC Soft Computer, Zhongde Gaoye, Blood Bank Computer Systems, Jinfeng Yitong, Fengde, IT Synergistics, Psyche Systems, Clinisys

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 137 pages
Market size 2025
$510
Million USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$782.2
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Blood Bank Information System market size is predicted to grow from US$ 510 million in 2025 to US$ 781 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

A Blood Bank Information System (BBIS) is a computerized management system designed to oversee and streamline the entire process of blood collection, storage, testing, and distribution. It enhances efficiency in managing blood resources, ensuring safety and traceability of blood products. The system provides real-time updates on blood inventory, records donor information, test results, and tracks the utilization of blood. This allows hospitals and medical institutions to optimize blood transfusion management, minimize waste, and ensure the safety of patients requiring blood.

The Blood Bank Information System (BBIS) market is primarily driven by the increasing demand for efficient blood management and tracking systems in healthcare. With a rising number of surgical procedures, trauma cases, and the prevalence of chronic diseases, hospitals and healthcare facilities need advanced systems to ensure the availability and proper utilization of blood supplies. Furthermore, advancements in technology such as automation, cloud-based solutions, and AI integration are significantly enhancing the capabilities of BBIS, allowing real-time data access, improved accuracy, and streamlined processes, thereby fueling market growth.

Despite the promising growth, the BBIS market faces several challenges. One of the key issues is the high initial cost associated with implementing these systems, which can be a barrier for smaller hospitals or clinics with limited budgets. Additionally, concerns around data security and privacy remain prevalent, as the sensitive nature of patient and donor information makes the systems vulnerable to cyber-attacks. Ensuring compliance with stringent regulations, such as HIPAA and GDPR, adds to the complexity of managing and maintaining these systems efficiently.

Global Blood Bank Information System key players include Roper Industries, Haemonetics, Cerner Corporation, McKesson, etc. Global top four manufacturers hold a share over 55%. North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 45 percent. In terms of product, Blood Bank Transfusion Service Module is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, followed by Blood Station.

This report presents a comprehensive overview of the global Blood Bank Information System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Blood Donor Management Module
  • Blood Bank Transfusion Service Module
  • Other

Segment by players, this report covers

  • Roper Industries
  • Haemonetics
  • Cerner Corporation
  • McKesson
  • Mak-System
  • Integrated Medical Systems
  • Mediware
  • Compugroup
  • SCC Soft Computer
  • Zhongde Gaoye
  • Blood Bank Computer Systems
  • Jinfeng Yitong
  • Fengde
  • IT Synergistics
  • Psyche Systems
  • Clinisys

Segment by Application

  • Hospital
  • Blood Station

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Bank Information System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Blood Station evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blood Bank Information System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$510
2025
Forecast
$782.2
2032
CAGR
6.3%
2025–2032
Regionen
5
global
Key companies
Roper IndustriesHaemoneticsCerner CorporationMcKessonMak-SystemIntegrated Medical SystemsMediwareCompugroup
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Blood Donor Management ModuleBlood Bank Transfusion Service ModuleOther
By Application
HospitalBlood Station

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Blood Donor Management Module
  • 3.1.3 Blood Bank Transfusion Service Module
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Blood Station
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Roper Industries
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Haemonetics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cerner Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 McKesson
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Mak-System
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Integrated Medical Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Mediware
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Compugroup
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 SCC Soft Computer
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Zhongde Gaoye
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Blood Bank Computer Systems
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Jinfeng Yitong
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Fengde
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 IT Synergistics
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Psyche Systems
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Clinisys
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Blood Bank Information System market?
The global Blood Bank Information System market is estimated at US$ 510 million in 2025 (base year) and is projected to reach US$ 781 million by 2032.
What is the forecast CAGR for the Blood Bank Information System market?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 510 million in 2025 to US$ 781 million in 2032, roughly 1.5 times its base-year value.
What is Blood Bank Information System?
A Blood Bank Information System (BBIS) is a computerized management system designed to oversee and streamline the entire process of blood collection, storage, testing, and distribution. It enhances efficiency in managing blood resources, ensuring safety and traceability of blood products. The system provides real-time updates on blood inventory, records donor information, test results, and tracks the utilization of blood.
How is the Blood Bank Information System market segmented by type?
By type, the market is segmented into Blood Donor Management Module, Blood Bank Transfusion Service Module and Other.
What are the key applications of Blood Bank Information System?
Key applications covered include Hospital and Blood Station.
Which companies are profiled in the Blood Bank Information System market report?
Key players profiled include Roper Industries, Haemonetics, Cerner Corporation, McKesson, Mak-System, Integrated Medical Systems, Mediware and Compugroup, among 16 companies covered in total.
What geographies does the Blood Bank Information System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Blood Bank Information System?
The Blood Bank Information System (BBIS) market is primarily driven by the increasing demand for efficient blood management and tracking systems in healthcare.
What are the main risks and barriers in the Blood Bank Information System market?
Despite the promising growth, the BBIS market faces several challenges.
Who should buy the Blood Bank Information System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Blood Station, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Bank Information System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.